This invention provides compounds of Formula I having the structure
wherein
A, Q, R3, and R4 are as defined hereinbefore in the specification,
or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.
这项发明提供了具有结构的Formula I化合物,其中A、Q、R3和R4如前文规定,或其药学上可接受的盐,适用于治疗与
胰岛素抵抗或高血糖相关的代谢性疾病。